Literature DB >> 18941605

Validation of QwikStar Catheter for left ventricular electromechanical mapping with NOGA XP system.

Marlos R Fernandes1, Guilherme V Silva, Yi Zheng, Edie M Oliveira, Cristiano O Cardoso, John Canales, Ricardo Sanz-Ruiz, Pilar Jimenez-Quevedo, Fred Baimbridge, Emerson C Perin.   

Abstract

Left ventricular electromechanical mapping (LVEM) is a method for mapping the left ventricular cavity in 3 dimensions by use of a catheter that samples points on the endocardial surface. These points provide data on unipolar voltage and linear local shortening, which can then be used to evaluate myocardial ischemia and viability. The new QwikStar multi-electrode catheter, which acquires data from multiple points simultaneously, potentially improves map quality and decreases mapping time in comparison with the single-point NogaStar catheter. Our study sought to validate the QwikStar catheter's LVEM capabilities in a porcine model of chronic ischemia.Eight pigs underwent ameroid placement over the proximal left circumflex artery, to induce chronic ischemia. In 60 days, LVEM was performed on each animal with the NogaStar and QwikStar catheters. Unipolar voltage and linear local shortening results were displayed in 9-segment polar maps. The unipolar voltage data from both maps were then correlated by means of linear regression.There were no adverse events during LVEM. Mapping time was similar for both groups (QwikStar, 44.6 +/- 25.62 min; NogaStar, 65.75 +/- 25.33 min; P = 0.13). Results of mean unipolar voltage maps acquired with the 2 catheters showed a moderate correlation (r =0.59, P <0.001). Selecting segments with more than 6 point samples increased the Pearson coefficient to 0.69 (P <0.001).Our findings show that the QwikStar catheter enables the reproducible performance of LVEM by sampling fewer points, which shortens procedure time, decreases manipulation of the left ventricular cavity, and might increase procedural safety.

Entities:  

Keywords:  Body surface potential mapping/methods; cell transplantation/methods; disease models, animal; electromyography/instrumentation/methods/standards; imaging, three-dimensional/instrumentation/methods/standards; infusions, endocardial; myocardial ischemia/diagnosis; safety; swine; ventricular function, left

Mesh:

Year:  2008        PMID: 18941605      PMCID: PMC2565544     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  18 in total

1.  Validation of viability assessment by electromechanical mapping by three-dimensional reconstruction with dobutamine stress echocardiography in patients with coronary artery disease.

Authors:  Athena Poppas; Florence H Sheehan; Mark Reisman; Verna Harms; Ran Kornowski
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

2.  Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.

Authors:  Dongming Hou; Eyas Al-Shaykh Youssef; Todd J Brinton; Ping Zhang; Pamela Rogers; Erik T Price; Alan C Yeung; Brian H Johnstone; Paul G Yock; Keith L March
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 3.  Methods of stem cell delivery in cardiac diseases.

Authors:  Emerson C Perin; Javier López
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2006-03

4.  Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability.

Authors:  R Kornowski; M K Hong; M B Leon
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

5.  Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis.

Authors:  Hung-Fat Tse; Sukumaran Thambar; Yok-Lam Kwong; Philip Rowlings; Greg Bellamy; Jane McCrohon; Bruce Bastian; John K F Chan; Gladys Lo; Chi-Lai Ho; Chu-Pak Lau
Journal:  Am J Cardiol       Date:  2006-05-04       Impact factor: 2.778

6.  Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium.

Authors:  R Kornowski; M K Hong; L Gepstein; S Goldstein; S Ellahham; S A Ben-Haim; M B Leon
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

7.  Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.

Authors:  Saskia L M A Beeres; Jeroen J Bax; Petra Dibbets; Marcel P M Stokkel; Katja Zeppenfeld; Willem E Fibbe; Ernst E van der Wall; Martin J Schalij; Douwe E Atsma
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

8.  Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function.

Authors:  Christian Templin; Daniel Kotlarz; Frederik Marquart; Joerg Faulhaber; Vanessa Brendecke; Arnd Schaefer; Dimitrios Tsikas; Tomasz Bonda; Denise Hilfiker-Kleiner; Lars Ohl; Hassan Y Naim; Reinhold Foerster; Helmut Drexler; Florian P Limbourg
Journal:  Basic Res Cardiol       Date:  2006-05-16       Impact factor: 17.165

9.  Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.

Authors:  Pieter C Smits; Robert-Jan M van Geuns; Don Poldermans; Manolis Bountioukos; Emile E M Onderwater; Chi Hang Lee; Alex P W M Maat; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

10.  A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

Authors:  Toby Freyman; Glenn Polin; Hashim Osman; Jody Crary; MinMin Lu; Lan Cheng; Maria Palasis; Robert L Wilensky
Journal:  Eur Heart J       Date:  2006-03-01       Impact factor: 29.983

View more
  4 in total

Review 1.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

Review 2.  Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.

Authors:  Peter J Psaltis; Robert D Simari; Martin Rodriguez-Porcel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

Review 3.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

4.  Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.

Authors:  Emerson C Perin; Mei Tian; Frank C Marini; Guilherme V Silva; Yi Zheng; Fred Baimbridge; Xin Quan; Marlos R Fernandes; Amir Gahremanpour; Daniel Young; Vincenzo Paolillo; Uday Mukhopadhyay; Agatha T Borne; Rajesh Uthamanthil; David Brammer; James Jackson; William K Decker; Amer M Najjar; Michael W Thomas; Andrei Volgin; Brian Rabinovich; Suren Soghomonyan; Hwan-Jeong Jeong; Jesse M Rios; David Steiner; Simon Robinson; Osama Mawlawi; Tinsu Pan; Jason Stafford; Vikas Kundra; Chun Li; Mian M Alauddin; James T Willerson; Elizabeth Shpall; Juri G Gelovani
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.